Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 995 | 0 | 1 | 13 | 72 |
| Receivables | N/A | N/A | 1 | N/A | N/A |
| Inventories | N/A | 1 | N/A | N/A | N/A |
| TOTAL | $999 | $1 | $2 | $48 | $102 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 37 | 47 | 60 |
| Intangibles | 0 | 65 | 193 | 207 | 208 |
| Other Non-Current Assets | 4 | 0 | 0 | 0 | 0 |
| TOTAL | $4 | $65 | $230 | $254 | $268 |
| Total Assets | $1,003 | $65 | $232 | $302 | $369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 745 | 405 |
| Accrued Expenses | N/A | 18 | N/A | 81 | 246 |
| TOTAL | $300 | $34 | $N/A | $1,946 | $1,833 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 69 | 0 | 2,112 | 0 | 0 |
| TOTAL | $69 | $N/A | $2,112 | $N/A | $N/A |
| Total Liabilities | $369 | $34 | $2,112 | $1,946 | $1,833 |
| Shareholders' Equity | |||||
| Common Shares | 166 | 0 | 55 | 55 | 14 |
| Retained earnings | -316 | -23 | -30,550 | -30,314 | -28,774 |
| Other shareholders' equity | -350 | 0 | 0 | 0 | 0 |
| TOTAL | $633 | $31 | $-1,880 | $-1,644 | $-1,464 |
| Total Liabilities And Equity | $1,003 | $65 | $232 | $302 | $369 |